How will US payers evaluate and manage digital therapeutics?

Overview

Digital health innovations can help people better manage chronic diseases and access healthcare when they need it, improving adherence to medications and preventing complications.

Join us for an introduction and review of digital health, and the current regulatory landscape, with a focus on how various US payers perceive these new innovations in healthcare. Experts from our Global Pricing and Market Access group will present original research on how US payer organizations currently evaluate and manage digital therapeutics, and their perspectives for the future.

Benjamin Schatzman

Benjamin Schatzman, Pharm.D

Principal, Global Pricing and Market Access

Dr. Benjamin Schatzman has over 21 years of managed care pharmacy experience, including PBM and Managed Care. His expertise includes formulary management, medical policy, payer access, health plan pharmacy operations, regulatory and governmental affairs work pertaining to pharmacy, PBM and specialty pharmacy oversight, and government-sponsored health plans including Medicaid, Medicare, and Health Insurance Exchange. Prior to joining ICON, he was Vice President of Pharmacy Plan Operations and Clinical Support at Molina Healthcare, a Fortune 500 company, where he helped oversee a $3 billion-plus pharmacy benefit.

Curran Sidhu

Curran Sidhu

Senior Analyst, Global Pricing and Market Access

Mr. Curran Sidhu joined ICON in 2017 and is based in San Diego, CA. He works with global pharma and medical device clients on projects involving value proposition development, pricing and market access strategy, and reimbursement strategy. His experience spans several therapeutic areas, including oncology, diabetes, immunology, ophthalmology, and orthopedics.